¿Su nivel de Lp(a) lo pone en riesgo?

Los niveles elevados de Lp(a) aumentan el riesgo de sufrir enfermedades cardiovasculares y accidentes cerebrovasculares.

[{"selector":"#anim-4ebaf444-c8a2-4468-9b88-fad798ba83cb [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Las partículas de Lp(a) pueden penetrar las paredes arteriales y promover la acumulación de placa.

[{"selector":"#anim-73b163af-a142-4739-8411-453dd047475a [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Los niveles altos de Lp(a) a menudo son hereditarios, por lo que se requieren pruebas genéticas para su diagnóstico.

[{"selector":"#anim-2d7372b4-6e52-4b6c-803c-a5b2fe8ee0c3 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

La Lp(a) contribuye a la inflamación y a la progresión de la aterosclerosis.

[{"selector":"#anim-a73bcc5b-514c-474f-b310-1cbb11bd6da5 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Los niveles elevados de Lp(a) están relacionados con un mayor riesgo de sufrir un ataque cardíaco y una enfermedad arterial periférica.

[{"selector":"#anim-c006e882-6630-48e9-8ed6-8a9776332354 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Los niveles de Lp(a) generalmente no se ven afectados por cambios en la dieta o el estilo de vida.

[{"selector":"#anim-b81d3bb8-32ff-438d-8b20-2b0f1bd3e2c1 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Algunos medicamentos, como la niacina y los inhibidores de PCSK9, pueden reducir los niveles de Lp(a).

[{"selector":"#anim-da9f5e57-ddbe-4bd6-b638-73656f059bf8 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Los niveles elevados de Lp(a) pueden requerir un tratamiento lipídico más agresivo.

[{"selector":"#anim-2898c56e-9c3f-46de-b2d4-dd715eb834fb [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Se recomienda la prueba de Lp(a) para aquellos con antecedentes familiares de enfermedad cardíaca.

[{"selector":"#anim-bed69661-9e13-4207-b8dd-c4865982502e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(21.874999829338595%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]

Los niveles elevados de Lp(a) no tratados pueden provocar enfermedades cardiovasculares prematuras.

[{"selector":"#anim-7fcf2740-5ff2-4a94-8c40-c81649c44d9c [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.552713678800501e-15%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

For More Info

[{"selector":"#anim-0a9efaff-b3f7-4b7e-af13-d8d3af311635 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}]